United States Premenstrual Syndrome Medicine Market Report 2018

January 2018 | 98 pages | ID: U7D9C326297EN
QYResearch

Abstracts

In this report, the United States Premenstrual Syndrome Medicine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Premenstrual Syndrome Medicine in these regions, from 2013 to 2025 (forecast).

United States Premenstrual Syndrome Medicine market competition by top manufacturers/players, with Premenstrual Syndrome Medicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Asarina Pharma AB
• Pherin Pharmaceuticals Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• PH-80PMD
• Estrogen
• Progesterone
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Home Care
• Hospital
• Clinic

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Premenstrual Syndrome Medicine Market Report 2018

1 PREMENSTRUAL SYNDROME MEDICINE OVERVIEW

1.1 Product Overview and Scope of Premenstrual Syndrome Medicine
1.2 Classification of Premenstrual Syndrome Medicine by Product Category
  1.2.1 United States Premenstrual Syndrome Medicine Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Premenstrual Syndrome Medicine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 PH-80PMD
  1.2.4 Estrogen
  1.2.5 Progesterone
  1.2.6 Others
1.3 United States Premenstrual Syndrome Medicine Market by Application/End Users
  1.3.1 United States Premenstrual Syndrome Medicine Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Home Care
  1.3.3 Hospital
  1.3.4 Clinic
1.4 United States Premenstrual Syndrome Medicine Market by Region
  1.4.1 United States Premenstrual Syndrome Medicine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Premenstrual Syndrome Medicine Status and Prospect (2013-2025)
  1.4.3 Southwest Premenstrual Syndrome Medicine Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Premenstrual Syndrome Medicine Status and Prospect (2013-2025)
  1.4.5 New England Premenstrual Syndrome Medicine Status and Prospect (2013-2025)
  1.4.6 The South Premenstrual Syndrome Medicine Status and Prospect (2013-2025)
  1.4.7 The Midwest Premenstrual Syndrome Medicine Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Premenstrual Syndrome Medicine (2013-2025)
  1.5.1 United States Premenstrual Syndrome Medicine Sales and Growth Rate (2013-2025)
  1.5.2 United States Premenstrual Syndrome Medicine Revenue and Growth Rate (2013-2025)

2 UNITED STATES PREMENSTRUAL SYNDROME MEDICINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Premenstrual Syndrome Medicine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Premenstrual Syndrome Medicine Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Premenstrual Syndrome Medicine Average Price by Players/Suppliers (2013-2018)
2.4 United States Premenstrual Syndrome Medicine Market Competitive Situation and Trends
  2.4.1 United States Premenstrual Syndrome Medicine Market Concentration Rate
  2.4.2 United States Premenstrual Syndrome Medicine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Premenstrual Syndrome Medicine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PREMENSTRUAL SYNDROME MEDICINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Premenstrual Syndrome Medicine Sales and Market Share by Region (2013-2018)
3.2 United States Premenstrual Syndrome Medicine Revenue and Market Share by Region (2013-2018)
3.3 United States Premenstrual Syndrome Medicine Price by Region (2013-2018)

4 UNITED STATES PREMENSTRUAL SYNDROME MEDICINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Premenstrual Syndrome Medicine Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Premenstrual Syndrome Medicine Revenue and Market Share by Type (2013-2018)
4.3 United States Premenstrual Syndrome Medicine Price by Type (2013-2018)
4.4 United States Premenstrual Syndrome Medicine Sales Growth Rate by Type (2013-2018)

5 UNITED STATES PREMENSTRUAL SYNDROME MEDICINE SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Premenstrual Syndrome Medicine Sales and Market Share by Application (2013-2018)
5.2 United States Premenstrual Syndrome Medicine Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES PREMENSTRUAL SYNDROME MEDICINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Asarina Pharma AB
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Premenstrual Syndrome Medicine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Asarina Pharma AB Premenstrual Syndrome Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Pherin Pharmaceuticals Inc
  6.2.2 Premenstrual Syndrome Medicine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview

7 PREMENSTRUAL SYNDROME MEDICINE MANUFACTURING COST ANALYSIS

7.1 Premenstrual Syndrome Medicine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Premenstrual Syndrome Medicine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Premenstrual Syndrome Medicine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Premenstrual Syndrome Medicine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PREMENSTRUAL SYNDROME MEDICINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Premenstrual Syndrome Medicine Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Premenstrual Syndrome Medicine Sales Volume Forecast by Type (2018-2025)
11.3 United States Premenstrual Syndrome Medicine Sales Volume Forecast by Application (2018-2025)
11.4 United States Premenstrual Syndrome Medicine Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Premenstrual Syndrome Medicine
Figure United States Premenstrual Syndrome Medicine Market Size (K Pcs) by Type (2013-2025)
Figure United States Premenstrual Syndrome Medicine Sales Volume Market Share by Type (Product Category) in 2017
Figure PH-80PMD Product Picture
Figure Estrogen Product Picture
Figure Progesterone Product Picture
Figure Others Product Picture
Figure United States Premenstrual Syndrome Medicine Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Premenstrual Syndrome Medicine by Application in 2017
Figure Home Care Examples
Table Key Downstream Customer in Home Care
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure United States Premenstrual Syndrome Medicine Market Size (Million USD) by Region (2013-2025)
Figure The West Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Premenstrual Syndrome Medicine Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Premenstrual Syndrome Medicine Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Premenstrual Syndrome Medicine Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Premenstrual Syndrome Medicine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Premenstrual Syndrome Medicine Sales Share by Players/Suppliers
Figure 2017 United States Premenstrual Syndrome Medicine Sales Share by Players/Suppliers
Figure United States Premenstrual Syndrome Medicine Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Premenstrual Syndrome Medicine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Premenstrual Syndrome Medicine Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Premenstrual Syndrome Medicine Revenue Share by Players/Suppliers
Figure 2017 United States Premenstrual Syndrome Medicine Revenue Share by Players/Suppliers
Table United States Market Premenstrual Syndrome Medicine Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Premenstrual Syndrome Medicine Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Premenstrual Syndrome Medicine Market Share of Top 3 Players/Suppliers
Figure United States Premenstrual Syndrome Medicine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Premenstrual Syndrome Medicine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Premenstrual Syndrome Medicine Product Category
Table United States Premenstrual Syndrome Medicine Sales (K Pcs) by Region (2013-2018)
Table United States Premenstrual Syndrome Medicine Sales Share by Region (2013-2018)
Figure United States Premenstrual Syndrome Medicine Sales Share by Region (2013-2018)
Figure United States Premenstrual Syndrome Medicine Sales Market Share by Region in 2017
Table United States Premenstrual Syndrome Medicine Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Premenstrual Syndrome Medicine Revenue Share by Region (2013-2018)
Figure United States Premenstrual Syndrome Medicine Revenue Market Share by Region (2013-2018)
Figure United States Premenstrual Syndrome Medicine Revenue Market Share by Region in 2017
Table United States Premenstrual Syndrome Medicine Price (USD/Pcs) by Region (2013-2018)
Table United States Premenstrual Syndrome Medicine Sales (K Pcs) by Type (2013-2018)
Table United States Premenstrual Syndrome Medicine Sales Share by Type (2013-2018)
Figure United States Premenstrual Syndrome Medicine Sales Share by Type (2013-2018)
Figure United States Premenstrual Syndrome Medicine Sales Market Share by Type in 2017
Table United States Premenstrual Syndrome Medicine Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Premenstrual Syndrome Medicine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Premenstrual Syndrome Medicine by Type (2013-2018)
Figure Revenue Market Share of Premenstrual Syndrome Medicine by Type in 2017
Table United States Premenstrual Syndrome Medicine Price (USD/Pcs) by Types (2013-2018)
Figure United States Premenstrual Syndrome Medicine Sales Growth Rate by Type (2013-2018)
Table United States Premenstrual Syndrome Medicine Sales (K Pcs) by Application (2013-2018)
Table United States Premenstrual Syndrome Medicine Sales Market Share by Application (2013-2018)
Figure United States Premenstrual Syndrome Medicine Sales Market Share by Application (2013-2018)
Figure United States Premenstrual Syndrome Medicine Sales Market Share by Application in 2017
Table United States Premenstrual Syndrome Medicine Sales Growth Rate by Application (2013-2018)
Figure United States Premenstrual Syndrome Medicine Sales Growth Rate by Application (2013-2018)
Table Asarina Pharma AB Basic Information List
Table Asarina Pharma AB Premenstrual Syndrome Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Asarina Pharma AB Premenstrual Syndrome Medicine Sales Growth Rate (2013-2018)
Figure Asarina Pharma AB Premenstrual Syndrome Medicine Sales Market Share in United States (2013-2018)
Figure Asarina Pharma AB Premenstrual Syndrome Medicine Revenue Market Share in United States (2013-2018)
Table Pherin Pharmaceuticals Inc Basic Information List
Table Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales Growth Rate (2013-2018)
Figure Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales Market Share in United States (2013-2018)
Figure Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Premenstrual Syndrome Medicine
Figure Manufacturing Process Analysis of Premenstrual Syndrome Medicine
Figure Premenstrual Syndrome Medicine Industrial Chain Analysis
Table Raw Materials Sources of Premenstrual Syndrome Medicine Major Players/Suppliers in 2017
Table Major Buyers of Premenstrual Syndrome Medicine
Table Distributors/Traders List
Figure United States Premenstrual Syndrome Medicine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Premenstrual Syndrome Medicine Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Premenstrual Syndrome Medicine Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Premenstrual Syndrome Medicine Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Premenstrual Syndrome Medicine Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Premenstrual Syndrome Medicine Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Premenstrual Syndrome Medicine Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Premenstrual Syndrome Medicine Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Premenstrual Syndrome Medicine Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Premenstrual Syndrome Medicine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Premenstrual Syndrome Medicine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Premenstrual Syndrome Medicine Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources